Weekly Rounds: COVID-19, Fighting a Disease With a Disease, Rise in RSV Infections, and More

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 24, 2023.

Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.

How Soon Is Another Booster Needed? Durability of Vaccine-Induced Immunity

Specifically for older individuals and immunocompromised individuals, a year could be too long.

Is the Rise in RSV Infections Associated With Immune Debt or SARS-CoV-2 Immune Dysfunction?

Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.

Mpox Emergence: A Review of the 2022-2023 Outbreak

Mpox (formerly “monkeypox”) is endemic in certain African countries but was rarely reported in the Western world until recently.

CROI Now Covers More Than HIV

The Conference on Retroviruses and Opportunistic Infections 2023 has research in COVID-19, mpox, hepatitis, and other viral infections, plus networking, and even Anthony Fauci, MD, speaking on his legacy.

COVID-19 Immunity: Catching a Disease to Prevent a Disease?

Catching COVID-19 to prevent a more severe case is not a good strategy, says Kevin Kavanagh, MD.